Months after the start of an infant formula shortage in the U.S, many parents are still struggling to find cans and bottles of certain brands, in part because a major formula plant has not yet ramped up production.
But the Abbott Nutrition formula plant in Sturgis, Michigan is poised to begin production of its main formula soon, a company CEO said recently, while other producers also plan increases in the U.S. that should ease shortages.
For now, however, the missing output from the Sturgis plant has extended a formula shortage that started in February.
A spokesman for Abbott Nutrition told The Washington Times that its Sturgis plant, which the FDA temporarily shuttered in February over safety issues, is not yet producing Similac, the nation’s most popular line of formula.